ArticleFuture science OA2025
The I/D variant of the
Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe purpose of our study was to investigate the prevalence of the I/D variant of the PATIENTS AND
methodsThe study group included 117 patients with severe COVID-19 and 100 with mild COVID-19. All patients underwent testing for the I/D variant of the
resultsThe genotype frequencies in the group of patients with severe and mild COVID-19 were as follows: II - 23.1% and 20.0%, ID - 50.4% and 52.0%, DD - 26.6% and 28.0%. These frequencies did not significantly differ from each other, nor did they differ in the population frequencies for the Ukrainian population. The study revealed that the level of diuresis in carriers of the ID genotype was significantly higher than that in patients with the II genotype (p = 0.009). Patients with the DD genotype had prolonged activated partial thromboplastin time compared with those with the ID genotype (p = 0.023).
conclusionsThe I/D variant of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.